Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

See DuPont (DD)’s Full Presentation as It Blasts Trian’s Proposals, Saying Split Would Cost Company Billions

Page 1 of 51

E. I. du Pont de Nemours and Company (NYSE:DD) has released a lengthy presentation in response to the proxy fight taking place between it and Nelson Peltz‘ activist fund Trian Partners, and some of the assertions made by that investor. Among other things, the fund is seeking the replacement of four members of the company’s board, and the breakup of the 212-year-old company into separate chemicals and agricultural businesses. Trian has claimed such a split could save the company anywhere from $2 to $4 billion annually. E. I. du Pont de Nemours and Company (NYSE:DD) paints quite a different picture in its presentation, claiming that not only would a split cost the company $4 billion initially, but that the company would lose $1 billion annually on top of that, due to increased administrative and legal fees. DuPont has urged shareholders to vote against Trian’s board nominees, declaring that none of them would add any value or skills relevant to shaping the company, and that they lack experience in the chemicals industry. 

In a response to the presentation, a Trian spokesperson told the Wall Street Journal that “DuPont is attempting to distract and mislead shareholders from the real issues at the company”.

Check out E. I. du Pont de Nemours and Company (NYSE:DD)’s full presentation below.

Page 1 of 51

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!